We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Review · November 02, 2020

Targeting the HIF2–VEGF Axis in RCC

Nature Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Medicine
Targeting the HIF2–VEGF Axis in Renal Cell Carcinoma
Nat. Med. 2020 Oct 05;[EPub Ahead of Print], TK Choueiri, WG Kaelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading